Publications by authors named "Y Bechor"
Introduction: Aging is associated with a progressive decline in the capacity for physical activity. The objective of the current study was to evaluate the effect of an intermittent hyperbaric oxygen therapy (HBOT) protocol on maximal physical performance and cardiac perfusion in sedentary older adults.
Methods: A randomized controlled clinical trial randomized 63 adults (> 64yrs) either to HBOT (n = 30) or control arms (n = 33) for three months.
Persistent post-concussion syndrome (PPCS) is a common and significant morbidity among children following traumatic brain injury (TBI) and the evidence for effective PPCS treatments remains limited. Recent studies have shown the beneficial effects of hyperbaric oxygen therapy (HBOT) in PPCS adult patients. This randomized, sham-control, double blind trial evaluated the effect of hyperbaric oxygen therapy (HBOT) on children (age 8-15) suffering from PPCS from mild-moderate TBI events six months to 10 years prior.
View Article and Find Full Text PDFIntroduction: Hyperbaric oxygen therapy (HBOT) has been used to increase endurance performance but has yet to be evaluated in placebo-controlled clinical trials. The current study aimed to evaluate the effect of an intermittent HBOT protocol on maximal physical performance and mitochondrial function in middle-aged master athletes.
Methods: A double-blind, randomized, placebo-controlled study on 37 healthy middle-aged (40-50) master athletes was performed between 2018 and 2020.
Introduction: Aging is characterized by the progressive loss of physiological capacity. Changes in gene expression can alter activity in defined age-related molecular pathways leading to cellular aging and increased aging disease susceptibility. The aim of the current study was to evaluate whether hyperbaric oxygen therapy (HBOT) affects gene expression in normal, non-pathological, aging adults.
View Article and Find Full Text PDFArticle Synopsis
- Skin biopsies were used in a clinical trial to assess the effects of hyperbaric oxygen therapy (HBOT) on aging skin, targeting key aging hallmarks like telomere shortening and senescent cells.
- The study involved 70 participants, with 13 males undergoing skin biopsies before, during, and after a three-month HBOT treatment, showing significant improvements in collagen density, elastic fiber length, and blood vessel count.
- Results suggest that HBOT can effectively improve skin aging by promoting blood vessel growth and reducing senescent cells, marking a significant breakthrough in understanding treatments for aging in humans.